Potential role of cannabidiol for seizure control in a patient with recurrent glioma

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)


    Glioma-related epilepsy significantly impact on patients’ quality of life, and can often be difficult to treat. Seizures cause significant morbidity for example neurocognitive deterioration, which may result from seizures themselves or due to adverse effects from antiepileptic drugs. Management of tumour with surgery, radiotherapy and chemotherapy may contribute to seizure control, but tumour related epilepsy is often refractory despite adequate treatment with standard anti-epileptic medications. Given the increasing interest in medicinal cannabis (or cannabidiol or CBD) as an anti-epileptic drug, CBD may help with seizure control in glioma patients with treatment-refractory seizures. Here we present a case of a young lady with recurrent glioma who had refractory seizures despite multiple anti-epileptic agents, who had significant benefit with CBD.

    Original languageEnglish
    Pages (from-to)275-276
    Number of pages2
    JournalJournal of Clinical Neuroscience
    Publication statusPublished - Jan 2020


    • Anti-epileptic
    • Cannabidiol
    • Epilepsy
    • Glioma
    • Treatment-refractory


    Dive into the research topics of 'Potential role of cannabidiol for seizure control in a patient with recurrent glioma'. Together they form a unique fingerprint.

    Cite this